Skip to main content

Orchard Therapeutics plc

ORTXDelisted Jan 24, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001748907

Orchard Therapeutics plc was delisted on Jan 24, 2024; its insiders filed their last Form 4 on Jan 24, 2024; 47 institutions reported holding it in 13F filings for Q4 2023, worth $122.0M in total; no superinvestor held it.

13F holders, Q2 2023

Institutional positions in Orchard Therapeutics plc as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
33
−2 vs. Q1 2023
Shares held
5.03M
−778.6K (−13.4%) vs. Q1 2023
Total value
$26.2M
−$5.00M (−16.0%) vs. Q1 2023
New holders
4
10 more added
Sold out
6
7 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ORTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 33 institutions
Q1 2021: 83 institutionsQ2 2021: 85 institutionsQ3 2021: 79 institutionsQ4 2021: 72 institutionsQ1 2022: 61 institutionsQ2 2022: 50 institutionsQ3 2022: 47 institutionsQ4 2022: 47 institutionsQ1 2023: 35 institutionsQ2 2023: 33 institutionsQ3 2023: 32 institutionsQ4 2023: 47 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2023: $26.2M
Q1 2021: $546.3MQ2 2021: $350.8MQ3 2021: $167.4MQ4 2021: $84.6MQ1 2022: $38.9MQ2 2022: $30.2MQ3 2022: $24.7MQ4 2022: $16.3MQ1 2023: $31.2MQ2 2023: $26.2MQ3 2023: $46.9MQ4 2023: $122.0MQ1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ORTX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 202347$122.0M
Q3 202332$46.9M
Q2 202333$26.2M
Q1 202335$31.2M
Q4 202247$16.3M
Q3 202247$24.7M
Q2 202250$30.2M
Q1 202261$38.9M
Q4 202172$84.6M
Q3 202179$167.4M
Q2 202185$350.8M
Q1 202183$546.3M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Orchard Therapeutics plc; share changes are against Q1 2023.

Institutions holding ORTX in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Royal Bank of Canada70$00.00%00.0%Unchanged
CWM, LLC83$00.00%00.0%Unchanged
Mine & Arao Wealth Creation & Management, LLC.10$530.00%00.0%Unchanged
Beaird Harris Wealth Management, LLC12$630.00%00.0%Unchanged
Concord Wealth Partners100$5210.00%00.0%Unchanged
Citigroup Inc110$5710.00%−167,622−99.9%Reduced
Rhumbline Advisers142$7360.00%+142New
Barclays PLC200$1.04K0.00%00.0%Unchanged
Group One Trading, L.P.301$1.56K0.00%+300+30,000.0%Added
UBS Group AG380$1.98K0.00%00.0%Unchanged
Bank of America Corp515$2.68K0.00%−3,270−86.4%Reduced
Advisor Group Holdings, Inc.957$4.99K0.00%+246+34.6%Added
Global Retirement Partners, LLC2,000$10.4K0.00%+2,000New
Banque Cantonale Vaudoise2,400$12.0K0.00%+2,400New
Woodline Partners LP10,000$52.1K0.00%00.0%Unchanged
Wells Fargo & Company11,250$58.6K0.00%+10,000+800.0%Added
Cormorant Asset Management, LP25,664$133.7K0.01%00.0%Unchanged
Morgan Stanley26,180$136.4K0.00%−3,850−12.8%Reduced
Goldman Sachs Group Inc28,364$147.8K0.00%+52+0.2%Added
Stifel Financial Corp28,414$148.0K0.00%+28,414New
JPMorgan Chase & Co33,419$173.4K0.00%−14,806−30.7%Reduced
FMR LLC41,228$214.0K0.00%00.0%Unchanged
UBS Oconnor LLC71,010$368.5K0.01%+3,498+5.2%Added
Acadian Asset Management LLC120,259$623.0K0.00%00.0%Unchanged
Citadel Advisors LLC125,521$651.5K0.00%+2,208+1.8%Added
Renaissance Technologies LLC125,218$652.0K0.00%+34,100+37.4%Added
Mariner, LLC154,410$804.0K0.00%+68,103+78.9%Added
Platinum Investment Management Ltd248,462$1.29M0.04%+129,334+108.6%Added
Deerfield Management Company, L.P. (Series C)316,169$1.65M0.04%00.0%Unchanged
Temasek Holdings (Private) Ltd352,379$1.84M0.01%−79,525−18.4%Reduced
Federated Hermes, Inc.508,222$2.65M0.01%−1,417,155−73.6%Reduced
CHI Advisors LLC755,738$3.94M1.20%−30,000−3.8%Reduced
Deep Track Capital, LP2,041,670$10.6M0.50%+875,000+75.0%Added
Kapitalo Investimentos Ltda0$00.00%−143,157−100.0%Sold out
Tang Capital Management LLC0$00.00%−50,000−100.0%Sold out
Forefront Analytics, LLC0$00.00%−14,654−100.0%Sold out
Sanders Morris Harris LLC0$00.00%−10,250−100.0%Sold out
Northwestern Mutual Wealth Management Co0$00.00%−150−100.0%Sold out
Armstrong Advisory Group, Inc0$00.00%−5−100.0%Sold out